Creabilis mission is to discover, develop and market novel and highly innovative therapeutic agents focused on dermatology. The Company has an exceptional knowledge base in a number of fields related to skin disorders, including inflammation/immunology, kinase inhibition and cytokine networking. This knowledge has supported the development of a rich pipeline of product candidates with the lead compound entering Phase II trials. Creabilis' strategy is to commercialise its expanding product pipeline directly through its own marketing efforts in niche indications and via licensing or co-marketing where appropriate.
Sede della società: via Ribes 5, 10010 Colleretto Giacosa (TO), Italy - Ufficio del Registro delle Imprese di Torino numero 08661490014 - Capitale sociale versato 1.500.000,00 Euro - Socio Unico: Creabilis SA